|
Abstract
Aim:
To evaluate the potential protective effects of mangosteen peel extract
against BPA-induced abnormalities on-pregnant mice fetus at implantation
stage and offspring at post-parturition.
Methodology: Pregnant mice were orally administered with BPA
(100mg kg-1 b.wt.) and mangosteen peel extract (200mg kg-1 b.wt.) for 16
days. In order to evaluate the effect of MPE treatment on fetus at
implantation stage, the pregnant mice were euthanized at day 18 and the fetus
number and morphology were examined. Another group of treated dams, were
allowed to undergo parturition for evaluating the of maternal weight, litter
size and offspring sex-skewness.
Results:
Upon feeding Mangosteen peel extract (MPE), the average daily weight gain of
dams were not significantly different from the control and BPA treated dams.
The fetus derived from BPA treated dams were detected with abnormalities such
as under development, haemorrhage and absence of vein, whereas fetus from dam
treated with MPE and BPA as well as control were normal. The average litter
size of all the treatment groups were not significantly different from the
control group. BPA treated mice had lower pups survival up to 6 weeks
compared to the groups treated with MPE and control. Test of proportion
analysis showed BPA-treated group had significantly higher fraction female
ratio.
Interpretation: BPA is known as endocrine disruptor
causing oxidative stress to female reproductive system, hence mangosteen peel
extract contains antioxidant substances that have the potential to ameliorate
the adverse effects of BPA exposure on dams during pregnancy and its fetus development.
Key
words:
Bisphenol A, Endocrine disruptor, Fertility, Mangosteen peel extract
|